1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (713) 792-4689
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy
Article first published online: 26 JAN 2009
DOI: 10.1002/cncr.24129
Copyright © 2009 American Cancer Society
Additional Information
How to Cite
Yi, M., Meric-Bernstam, F., Middleton, L. P., Arun, B. K., Bedrosian, I., Babiera, G. V., Hwang, R. F., Kuerer, H. M., Yang, W. and Hunt, K. K. (2009), Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer, 115: 962–971. doi: 10.1002/cncr.24129
Publication History
- Issue published online: 18 FEB 2009
- Article first published online: 26 JAN 2009
- Manuscript Accepted: 2 OCT 2008
- Manuscript Revised: 15 SEP 2008
- Manuscript Received: 2 JUN 2008
References
- 1,,, et al. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer. 2004; 101: 1977-1986.Direct Link:
- 2,,, et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol. 2005; 23: 4275-4286.
- 3,,,. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. 1999; 25: 584-589.
- 4,. Bilateral primary breast cancer, a prospective clinicopathological study. Cancer. 1964; 17: 1501-1527.Direct Link:
- 5,,, et al. Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol. 1999; 6: 546-552.
- 6,,, et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol. 2001; 19: 3938-3943.
- 7,,, et al. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer. 2005; 93: 287-292.
- 8,,,,,. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg. 2000; 180: 439-445.
- 9,,, et al. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer. 2006; 107: 1440-1447.Direct Link:
- 10,,,,. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst. 1994; 86: 620-625.
- 11,,, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999; 91: 1541-1548.
- 12,,, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989; 81: 1879-1886.
- 13,,,,. Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001; 93: 358-366.
- 14,,,. Validation of the Gail et al model for predicting individual breast cancer risk. J Natl Cancer Inst. 1994; 86: 600-607.
- 15,,,,. Breast cancer risk correlates with level of atypia in prophylactic mastectomy (PM) specimens. Ann Surg Oncol. 2004; 11( suppl 2): S94.
- 16. A new look at the statistical model identification. IEEE Trans Automatic Control. 1974; 19: 716-723.
- 17,,, et al. Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer. Ann Surg Oncol. 1998; 5: 529-538.
- 18,,. Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma. Cancer. 1986; 57: 897-903.Direct Link:
- 19,,,,,. Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg. 1985; 201: 667-677.
- 20,,,,,. Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol. 2007; 14: 2425-2427.
- 21,,,,. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007; 25: 5203-5209.
- 22,,. Morphologic types of breast cancer: age, bilaterality, and family history. South Med J. 1980; 73: 28-32.
- 23
- 24,,,. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004; 6: R149-R156.
- 25,,. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 1982; 91: 234-240.
- 26,,, et al. A case-control study of unilateral and bilateral breast carcinoma patients. Cancer. 2001; 91: 1845-1853.Direct Link:
- 27,,. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003; 56: 1038-1045.
- 28,. Epidemiology of breast cancer in older women: implications for future healthcare. Drugs Aging. 2001; 18: 761-772.
- 29,,,,. Prognostic significance of benign proliferative breast disease. Cancer. 1993; 71: 3896-3907.Direct Link:
- 30,,, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993; 71: 1258-1265.Direct Link:
- 31,,,. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992; 267: 941-944.
- 32,,, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997; 6: 297-301.
- 33,,,,,. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003; 361: 125-129.
- 34,,, et al. Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol. 2002; 26: 421-430.
- 35. A working model for the time sequence of genetic changes in breast tumorigenesis. J Am Coll Surg. 2002; 194: 202-216.
- 36. The long and short of chromosome 11 in breast cancer. Am J Pathol. 1998; 153: 5-9.
- 37,,, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007; 356: 1295-1303.
- 38,,, et al. Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst. 1991; 83: 1299-1306.
- 39